New York, April 14, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Senolytic Drugs Market, By Type, By Application, By Distribution Channel, By Region, Competition Forecast and Opportunities, 2017-2027” – https://www.reportlinker.com/p06267909/?utm_source=GNW
The global senolytic drugs market is expected to grow at a significant rate during the forecast period.The market growth can be attributed to the rising demands for anti-aging therapeutics and pharmaceuticals.
Advances in pharmaceutical drugs and the increasing need for healthy lifespan are accelerating the growth of the global senolytic drugs market.Senescence is a condition or process where cell ages and permanently stop dividing but does not die.
In some time, these cells can start accumulating and form a tumor or the development of cancer.The biological process can also result in weaker eyesight, skin wrinkling, lesser hearing capacity, etc.
Senolytic drugs are designed to target the senescent cells and destroy them with their effects. Increasing demand for anti-aging drugs and pharmaceutical products to increase the lifespan of human beings are expected to drive the growth of the senolytic drugs market. According to the U.N. Economic and Social Affairs statistics, the number of people aged 65 years and above is expected to grow by 120% and reach around 1.5 billion by 2050. Thus, the increasing geriatric population across the globe is anticipated to propel the growth of the global senolytic drugs market. Moreover, the rising incidences of age-related disorders like cataracts, glaucoma, neurodegenerative diseases, cardiovascular diseases, pulmonary infections, etc., and sedentary lifestyle among the global population are driving the growth of the global senolytic drugs market. The emergence of advanced technologies, from gene therapy to stem cells, and ongoing research activities for innovation in pharmaceutical drugs are anticipated to fuel the growth of the global…
